This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Brief Intervention for Rural Women at High Risk for HIV/HCV

Sponsored by Michele Staton

About this trial

Last updated 7 years ago

Study ID

5R01DA033866-02

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18+ Years
Female

Trial Timing

Ended 7 years ago

What is this trial about?

The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.

What are the participation requirements?

Inclusion Criteria

* ASSIST score of 4+

* engagement in at least one sex risk behavior in the past 3 months

* willingness to participate in brief intervention sessions

* no evidence of cognitive impairment

* no evidence of active psychosis (currently experiencing hallucinations)

* no self-reported current symptoms of physical withdrawal from a recent episode of drug use

* incarceration period of 1 week - 3 months in order to complete intervention sessions

Exclusion Criteria

* ASSIST score of <4

* no engagement in at least one sex risk behavior in the past 3 months

* not willing to participate in brief intervention sessions

* evidence of cognitive impairment

* evidence of active psychosis (currently experiencing hallucinations)

* self-reported current symptoms of physical withdrawal from a recent episode of drug use

* incarceration period of less than 1 week or greater than 3 months in order to complete intervention sessions